Today's Veterinary Business

AUG 2018

Today’s Veterinary Business provides information and resources designed to help veterinarians and office management improve the financial performance of their practices, allowing them to increase the level of patient care and client service.

Issue link: https://todaysveterinarybusiness.epubxp.com/i/1007483

Contents of this Issue

Navigation

Page 49 of 75

We are committed to supporting the use of nonadjuvanted vaccines in feline patients, throughout their life. We understand, however, that patients sometimes move, or are otherwise lost to observation, making it impossible to verify their complete vaccination history. Our PUREVAX ® Guarantee* therefore falls into three tiers: FELINE GUARANTEE CUSTOMER SATISFACTION GUARANTEE Diagnosis In the event that a cat is definitively diagnosed with an injection-site sarcoma: Guarantee Tier Tier 1 Tier 2 Tier 3 Criteria AND if that feline patient has been exclusively vaccinated with PUREVAX nonadjuvanted feline vaccines over its entire lifetime, AND if that feline patient has been exclusively vaccinated with PUREVAX during the most recent 5 years of their life, AND if that feline patient's LAST vaccination was with a PUREVAX nonadjuvanted feline vaccine but the patient does not otherwise have a documented history of PUREVAX- only vaccination, Support We will support standard and reasonable diagnostic and treatment costs up to $5,000. We will support standard and reasonable diagnostic and treatment costs up to $3,000. We will support standard and reasonable diagnostic and treatment costs up to $1,500. PURE, PROVEN PROTECTION State the Solution PUREVAX ® is the only complete line of nonadjuvanted feline vaccines, offering a variety of convenient combinations. By using PUREVAX vaccines we can reduce the potential risks associated with adjuvants. Make Your Recommendation I am recommending PUREVAX vaccines for all of our feline patients. Do you have any questions? An adjuvant is a substance that is added to a vaccine to enhance the body's immune response to the vaccine. Adjuvants have been associated with injection site reaction, injection site granuloma, and chronic inflammation in cats. 2,4 4 Greene CE, Levy JK. Immunoprophylaxis. In: Greene CE, ed. Infectious Diseases of the Dog and Cat. 4th ed. St. Louis, MO: Elsevier Saunders;2012:1184-1188. Review the Issue with Your Practice Team *Visit BI-connect.com or contact a Boehringer Ingelheim Customer Care Representative at 1-888-637-4251 for complete details about the Customer Satisfaction Guarantee.

Articles in this issue

Links on this page

Archives of this issue

view archives of Today's Veterinary Business - AUG 2018